| Characteristic | Overall N = 4971 |
Low Expression N = 2491 |
High Expression N = 2481 |
p-value2 |
|---|---|---|---|---|
| PTGES3 Expression (Z-score) | <0.001 | |||
| Mean ± SD | 0.06 ± 1.03 | -0.73 ± 0.63 | 0.85 ± 0.69 | |
| Age Group | 0.786 | |||
| ≤65 | 236.0 (48.5%) | 120.0 (49.2%) | 116.0 (47.7%) | |
| >65 | 251.0 (51.5%) | 124.0 (50.8%) | 127.0 (52.3%) | |
| Missing | 10 | 5 | 5 | |
| Gender | 0.019 | |||
| Male | 228.0 (45.9%) | 101.0 (40.6%) | 127.0 (51.2%) | |
| Female | 269.0 (54.1%) | 148.0 (59.4%) | 121.0 (48.8%) | |
| AJCC Stage | 0.044 | |||
| I | 267.0 (54.5%) | 145.0 (59.4%) | 122.0 (49.6%) | |
| II | 118.0 (24.1%) | 53.0 (21.7%) | 65.0 (26.4%) | |
| III | 80.0 (16.3%) | 39.0 (16.0%) | 41.0 (16.7%) | |
| IV | 25.0 (5.1%) | 7.0 (2.9%) | 18.0 (7.3%) | |
| Missing | 7 | 5 | 2 | |
| T Stage | 0.019 | |||
| T1 | 166.0 (33.6%) | 99.0 (40.1%) | 67.0 (27.1%) | |
| T2 | 267.0 (54.0%) | 120.0 (48.6%) | 147.0 (59.5%) | |
| T3 | 43.0 (8.7%) | 21.0 (8.5%) | 22.0 (8.9%) | |
| T4 | 18.0 (3.6%) | 7.0 (2.8%) | 11.0 (4.5%) | |
| Missing | 3 | 2 | 1 | |
| N Stage | 0.182 | |||
| N0 | 321.0 (66.3%) | 168.0 (70.3%) | 153.0 (62.4%) | |
| N1 | 94.0 (19.4%) | 40.0 (16.7%) | 54.0 (22.0%) | |
| N2 | 69.0 (14.3%) | 31.0 (13.0%) | 38.0 (15.5%) | |
| N3 | 0.0 (0.0%) | 0.0 (0.0%) | 0.0 (0.0%) | |
| Missing | 13 | 10 | 3 | |
| M Stage | 0.057 | |||
| M0 | 331.0 (93.2%) | 151.0 (96.2%) | 180.0 (90.9%) | |
| M1 | 24.0 (6.8%) | 6.0 (3.8%) | 18.0 (9.1%) | |
| Missing | 142 | 92 | 50 | |
| 1 n (%) | ||||
| 2 Welch Two Sample t-test; Fisher’s exact test | ||||